Chugai Pharma Europe Ltd.

Chugai Pharmaceutical Establishes U.S. Partnering Office to Accelerate Global Open Innovation Strategy

- Chugai Pharmaceutical announced the establishment of a new partnering office in South San Francisco, set to begin operations in January 2026 under the leadership of Andrew Wong. - The office will strengthen Chugai's network with U.S. academia and startups while advancing strategic external partnership activities as part of the company's goal to become a top global healthcare innovator by 2030. - This expansion complements Chugai's existing global partnering network, including operations in Japan, the UK, and Singapore, along with the Chugai Venture Fund in Boston. - The initiative positions open innovation as a key driver for Chugai's growth strategy, focusing on technology acquisition and target identification synergies with the company's drug discovery capabilities.